Global Hepatitis B and C Diagnostics Market 2021-2025
Technavio has been monitoring the hepatitis B and C diagnostics market and it is poised to grow by USD 1.72 bn during 2021-2025, progressing at a CAGR of 6.22% during the forecast period. Our report on the hepatitis B and C diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing demand for molecular diagnostics in diagnosis of HBV and HCV and rising demand for POC diagnostics. In addition, the growing demand for molecular diagnostics in diagnosis of HBV and HCV is anticipated to boost the growth of the market as well.
The hepatitis B and C diagnostics market analysis includes the procedure and diseases segment and geographic landscape.
Technavio's hepatitis B and C diagnostics market is segmented as below:
By Geographical Landscape
- North America
This study identifies the strategies of healthcare organizations toward simplifying diagnostic process as one of the prime reasons driving the hepatitis B and C diagnostics market growth during the next few years.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on hepatitis B and C diagnostics market covers the following areas:
- Hepatitis B and C diagnostics market sizing
- Hepatitis B and C diagnostics market forecast
- Hepatitis B and C diagnostics market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading hepatitis B and C diagnostics market vendors that include Abbott Laboratories, bioMerieux SA, Danaher Corp., DiaSorin SpA, Enzo Biochem Inc., F. Hoffmann-La Roche Ltd., PerkinElmer Inc., QIAGEN N.V, Quest Diagnostics Inc., and Siemens Healthineers AG. Also, the hepatitis B and C diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.